Tribune Therapeutics 🇸🇪
Series A · €23M
Nordic biotech developing CCN5-mimicking anti-fibrotic therapies (lead TRX-44 for IPF)
About Tribune Therapeutics
Tribune Therapeutics is a Sweden-based company founded in 2020, now around 12 people. It has raised $27.1M in disclosed funding. FundFinder classes it as Health & Bio.
Founder: Ole Joergen Kaasboell (Board observer; previously Førde Sentralsjukehus, General practice; University of Oslo).
Its investors also appear on FundFinder's most-active lists for Series A · Healthcare & Wellbeing (54 funds), Series A · Life Sciences (20 funds), Series A · AI (62 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Want the latest on Tribune Therapeutics? Our research agent pulls the current
description, latest round and full investor base from public sources (about a minute).
Series A · €23M · Mar 2025
- HealthCap — HealthCap is a life sciences venture investor and company creator based in Stockholm and founded in 1996.
- Industrifonden — Evergreen Swedish venture capital fund founded in 1979 and based in Stockholm. · cheques £750k – £3.8M